Syra Health Corp. (NASDAQ:SYRA) Short Interest Update

Syra Health Corp. (NASDAQ:SYRAGet Free Report) was the recipient of a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 403,800 shares, a drop of 44.5% from the March 15th total of 728,200 shares. Currently, 4.1% of the shares of the company are short sold. Based on an average daily trading volume, of 2,220,000 shares, the short-interest ratio is presently 0.2 days.

Syra Health Stock Down 17.9 %

Shares of SYRA traded down $0.02 during mid-day trading on Friday, hitting $0.10. 3,847,930 shares of the company’s stock were exchanged, compared to its average volume of 839,555. The stock’s 50-day simple moving average is $0.32 and its 200-day simple moving average is $0.39. The firm has a market cap of $1.18 million, a price-to-earnings ratio of -0.16 and a beta of 3.47. Syra Health has a 52 week low of $0.10 and a 52 week high of $2.27.

Syra Health (NASDAQ:SYRAGet Free Report) last announced its quarterly earnings results on Tuesday, March 11th. The company reported ($0.05) earnings per share (EPS) for the quarter. The company had revenue of $2.00 million for the quarter, compared to analyst estimates of $2.01 million. Syra Health had a negative return on equity of 131.94% and a negative net margin of 54.90%. Analysts forecast that Syra Health will post -0.53 earnings per share for the current fiscal year.

About Syra Health

(Get Free Report)

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions.

Featured Articles

Receive News & Ratings for Syra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syra Health and related companies with MarketBeat.com's FREE daily email newsletter.